• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CPI - DEL CARIBE INGEVITY; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CPI - DEL CARIBE INGEVITY; IMPLANTABLE LEAD Back to Search Results
Model Number 7741
Device Problems Pacing Problem (1439); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bacterial Infection (1735); Emotional Changes (1831); Scar Tissue (2060); Complaint, Ill-Defined (2331); Depression (2361); Post Operative Wound Infection (2446)
Event Date 12/12/2017
Event Type  Injury  
Manufacturer Narrative
The local area sales representative was contacted for additional information.At this time, no further information is available.Should additional information become available this report will be updated.
 
Event Description
Boston scientific received information that the patient implanted with this pacemaker, right atrial (ra) and right ventricular (rv) lead developed cellulitis in the device pocket incision resulting in a 7 day hospital stay post system implant.Subsequently, the patient reported experiencing a high heart rate in the 159 beats per minute (bpm) range and felt like they couldn't move and like they were going to pass out.The patient was seen by the paramedics who noted no anomalies.Additionally, the patient reported experiencing emotional distress related to the system implant and incision scar.Boston scientific technical services (ts) referred the patient to their physician for follow up.No additional adverse patient effects were reported.This product remains implanted and in service.
 
Manufacturer Narrative
As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Event Description
Additional information was received that a subsequent device check was performed and noted no anomalies in relation to the patient's reported high rate.Monitoring will be continued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INGEVITY
Type of Device
IMPLANTABLE LEAD
Manufacturer (Section D)
CPI - DEL CARIBE
guidant puerto rico b. v.
dorado PR
Manufacturer (Section G)
CPI - DEL CARIBE
guidant puerto rico b. v.
dorado PR
Manufacturer Contact
tim degroot
4100 hamline ave. n
st. paul, MN 
6515826168
MDR Report Key7216345
MDR Text Key98114318
Report Number2124215-2018-01489
Device Sequence Number1
Product Code LWP
UDI-Device Identifier00802526523458
UDI-Public00802526523458
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150012/S000
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Patient
Type of Report Initial,Followup
Report Date 01/21/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date11/21/2019
Device Model Number7741
Other Device ID NumberINGEVITY MRI
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 12/22/2017
Initial Date FDA Received01/24/2018
Supplement Dates Manufacturer Received01/21/2018
Supplement Dates FDA Received04/11/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/21/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
7740; 7741; L331
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age49 YR
-
-